Search filters

Filters
Clear All

Phase

  • 183
  • 156
  • 2
  • 194
  • 1
  • 148
  • 17
  • 396
  • 1237
  • 588
  • 29
  • 49
  • 3
  • 1162
  • 1237
  • 6
  • 3
  • 1240

Found 1243 All Conditions trials

A listing of All Conditions medical research trials actively recruiting patient volunteers. Search for closest city to find more detailed information on a research study in your area.

18 years - 65 years
All genders
The purpose of this study is to explore possible neurological complications resulting from prior COVID-19 infection. Neurological symptoms, including ‘brain fog’, depression, and/or anxiety can be disabling. This study aims to determine the prevalence and severity of these symptoms. Unfortunately, little is known about these neuropsychiatric symptoms, particularly in patients …
 Nasal Inhalation Influences on Smell Function
18 years - 100 years
All genders
The aim of this study is to see whether nasal inhalation can help recover smell loss.Quantitative olfactory testing will be initially performed on the participants.  Such testing will require approximately one hour of the participant’s time. Each participant will subsequently be sent in the mail a box that contains a set of …
18 years - 65 years
All genders
MS is a life-long disease that can clinically manifest at a wide range of ages. Lesions in the white matter of the brain can be found at any age in MS patients. How these lesions may affect functioning of the brain is an area we aim to explore. Although connections …
 XCI Maintenance in Scleroderma and Related Female-Biased Diseases
35 years - 90 years
All genders
The research study is being done to understand both why and how scleroderma and related female-biased diseases affect women and men differently.  Though we do not know what causes these diseases, we do know that women are much more likely to develop them than men.  We are studying how the …
 Healthy Volunteer Study for Herpes Vaccine (BNT163-01)
18 years - 55 years
All genders
Phase 1
The research study is being conducted to determine the best dose of an investigational vaccine called BNT163, and to determine if the vaccine is safe and well-tolerated. An investigational vaccine is a vaccine that is not approved by the US Food and Drug Administration (FDA), for use outside of this …
 General Screening Protocol for Affected and Unaffected Participants in Studies of Alcohol Use Disorder.
18 years - 75 years
Male
The goal is to conduct a screening procedure to be used in evaluating individuals either with or without an alcohol use disorder (AUD) to determine whether it is safe and appropriate for them to participate in a clinical trial, imaging study, genetic study, or other research protocol that matches their …
 Effects of opioid use disorder and non-fatal overdose on tau pathology; a [18F]PI-2620 PET/CT study
18 years - 60 years
All genders
Phase 2
This study is being conducted to learn more about how opioid use and opioid overdose affects tau levels in the brain. Tau is a protein in the brain that helps stabilize nerve cells structure. We will study tau levels in the brain using a type of Positron Emission Tomography (PET/CT) …
 FRESCO Study
18 years - 100 years
All genders
This research study is being conducted to compare items in the online Penn Healthy Diet (PHD) survey to data from a 24-hour dietary recall using the online ASA24 Dietary Assessment Tool, and to validate the scoring algorithm developed for the PHD survey. We would also like to find out if metabolites …
 INFORM Study
18 years - 100 years
All genders
Join a paid research study on health information on social media!The research study is being conducted to understand how health information and misinformation is shared and interacted with through Facebook wall posts, Twitter posts, and Google and YouTube searches. We’re interested in learning more about how people use information on …
18 years - 80 years
All genders
Phase 2
SAR443820 is a selective, orally bioavailable, central nervous system (CNS)-penetrant, receptor-interacting serine/threonine-protein kinase 1 (RIPK1) inhibitor. The aim of this Phase 2 study is to determine the efficacy, safety, tolerability, pharmacokinetics (PK), and pharmacodynamics (PD) of SAR443820 in treating adult participants with amyotrophic lateral sclerosis (ALS).
101 - 110 of 1243